Antiphospholipid antibodies and cell activation: crucial role of p38 MAPK pathway.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 799, doi. 10.1191/0961203305lu2160ed
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 2005 AND VI 14 AND IP 10
Results: 16
1
2
Review: intravenous immunoglobulin therapy and thromboembolic complications.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 802, doi. 10.1191/0961203303lu2168rr
- By:
- Publication type:
- Article
3
Lymphocyte subpopulations and intima media thickness in primary antiphospholipd syndrome.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 809, doi. 10.1191/0961203305lu2181oa
- By:
- Publication type:
- Article
4
Mast cells, TGF-β1 and myofibroblasts expression in lupus nephritis outcome.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 814, doi. 10.1191/0961203305lu2188oa
- By:
- Publication type:
- Article
5
Serositis related to systemic lupus erythematosus: prevalence and outcome.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 822, doi. 10.1191/0961203305lu2187oa
- By:
- Publication type:
- Article
6
Acute lupus myocarditis: clinical features and outcome of an oriental case series.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 827, doi. 10.1191/0961203305lu2228oa
- By:
- Publication type:
- Article
7
High sensitivity, specificity and predictive value of the Connective Tissue Disease Screening Questionnaire among urban African–American women.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 832, doi. 10.1191/0961203305lu2227oa
- By:
- Publication type:
- Article
8
Clinical and serological features of 35 patients with anti-Ki autoantibodies.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 837, doi. 10.1191/0961203305lu2226oa
- By:
- Publication type:
- Article
9
The functional p53 codon 72 polymorphism is associated with systemic lupus erythematosus.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 842, doi. 10.1191/0961203305lu2224oa
- By:
- Publication type:
- Article
10
QT-interval parameters are increased in systemic lupus erythematosus patients.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 846, doi. 10.1191/0961203305lu2225oa
- By:
- Publication type:
- Article
11
Can systemic lupus erythematosus be the cause of collapsing glomerulopathy?
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 853, doi. 10.1191/0961203305lu2162cr
- By:
- Publication type:
- Article
12
Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 856, doi. 10.1191/0961203305lu2163cr
- By:
- Publication type:
- Article
13
Elimination of anticardiolipin antibodies and cessation of cognitive decline in a UV-A1-irradiated systemic lupus erythematosus patient.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 859, doi. 10.1191/0961203305lu2164cr
- By:
- Publication type:
- Article
14
Epidemiology of systemic lupus erythematosus in rural Wisconsin.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 862, doi. 10.1191/0961203305lu2182xx
- By:
- Publication type:
- Article
15
Ethnic disparities in health and disease: the need to account for ancestral admixture when estimating the genetic contribution to both (LUMINA XXVI).
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 867, doi. 10.1191/0961203305lu2184xx
- By:
- Publication type:
- Article
16
Avascular necrosis prevention with lipitor in lupus erythematosus.
- Published in:
- Lupus, 2005, v. 14, n. 10, p. 869, doi. 10.1191/0961203305lu2189xx
- By:
- Publication type:
- Article